MedPath
HSA Approval

ELREXFIO SOLUTION FOR INJECTION 76 MG/1.9 ML

SIN17156P

ELREXFIO SOLUTION FOR INJECTION 76 MG/1.9 ML

ELREXFIO SOLUTION FOR INJECTION 76 MG/1.9 ML

December 31, 2024

PFIZER PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPFIZER PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

SUBCUTANEOUS

Medical Information

L01FX32

Manufacturer Information

PFIZER PRIVATE LIMITED

Pharmacia & Upjohn Company LLC

Active Ingredients

Elranatamab

76 mg/1.9 ml

Elranatamab

Documents

Package Inserts

ELREXFIO PI.pdf

Approved: December 31, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ELREXFIO SOLUTION FOR INJECTION 76 MG/1.9 ML - HSA Approval | MedPath